Efficacy and Safety of Apixaban in the Patients Undergoing the Ablation of Atrial Fibrillation
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and Safety of Apixaban in the Patients Undergoing the Ablation of Atrial Fibrillation
Authors
Keywords
-
Journal
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
Volume 38, Issue 2, Pages 155-163
Publisher
Wiley
Online
2014-12-09
DOI
10.1111/pace.12553
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Meta-Analysis of Risk of Stroke or Transient Ischemic Attack With Dabigatran for Atrial Fibrillation Ablation
- (2014) Partha Sardar et al. AMERICAN JOURNAL OF CARDIOLOGY
- Evaluation of the effect of naproxen on the pharmacokinetics and pharmacodynamics of apixaban
- (2014) Charles Frost et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Periprocedural Stroke and Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation With Different Anticoagulation Management
- (2014) Luigi Di Biase et al. CIRCULATION
- Does periprocedural anticoagulation management of atrial fibrillation affect the prevalence of silent thromboembolic lesion detected by diffusion cerebral magnetic resonance imaging in patients undergoing radiofrequency atrial fibrillation ablation with open irrigated catheters? Results from a prospective multicenter study
- (2014) Luigi Di Biase et al. HEART RHYTHM
- Feasibility and Safety of Uninterrupted Rivaroxaban for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation
- (2014) Dhanunjaya Lakkireddy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Dabigatran versus Warfarin Therapy for Uninterrupted Oral Anticoagulation During Atrial Fibrillation Ablation
- (2013) WILLIAM MADDOX et al. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
- Reversal of Apixaban Induced Alterations in Hemostasis by Different Coagulation Factor Concentrates: Significance of Studies In Vitro with Circulating Human Blood
- (2013) Gines Escolar et al. PLoS One
- Effective elimination of dabigatran by haemodialysis
- (2013) Stephan Formella et al. THROMBOSIS AND HAEMOSTASIS
- Assessment of apixaban plasma levels by laboratory tests: suitability of three anti-Xa assays
- (2013) Claire Flaujac et al. THROMBOSIS AND HAEMOSTASIS
- Efficacy and Safety of Periprocedural Dabigatran in Patients Undergoing Catheter Ablation of Atrial Fibrillation
- (2012) Kenichi Kaseno et al. CIRCULATION JOURNAL
- Dabigatran vs warfarin for radiofrequency catheter ablation of atrial fibrillation
- (2012) Jin-Seok Kim et al. HEART RHYTHM
- Differences in intraprocedural ACTs with standardized heparin dosing during catheter ablation for atrial fibrillation in patients treated with dabigatran vs. patients on uninterrupted warfarin
- (2012) Sai V. Konduru et al. JOURNAL OF INTERVENTIONAL CARDIAC ELECTROPHYSIOLOGY
- Feasibility and Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Radiofrequency Ablation for Atrial Fibrillation
- (2012) Dhanunjaya Lakkireddy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of non-specific reversal agents on anticoagulant activity of dabigatran and rivaroxaban
- (2012) Raphael Marlu et al. THROMBOSIS AND HAEMOSTASIS
- Reversal of Rivaroxaban and Dabigatran by Prothrombin Complex Concentrate
- (2011) Elise S. Eerenberg et al. CIRCULATION
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Periprocedural Stroke and Management of Major Bleeding Complications in Patients Undergoing Catheter Ablation of Atrial Fibrillation
- (2010) Luigi Di Biase et al. CIRCULATION
- Drug and dietary interactions of the new and emerging oral anticoagulants
- (2010) J. M. Walenga et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Clinical laboratory measurement of direct factor Xa inhibitors: Anti-Xa assay is preferable to prothrombin time assay
- (2010) Zhaoqing Wang et al. THROMBOSIS AND HAEMOSTASIS
- Updated Worldwide Survey on the Methods, Efficacy, and Safety of Catheter Ablation for Human Atrial Fibrillation
- (2009) Riccardo Cappato et al. Circulation-Arrhythmia and Electrophysiology
- Radiofrequency ablation of atrial fibrillation under therapeutic international normalized ratio: A safe and efficacious periprocedural anticoagulation strategy
- (2009) Ayman A. Hussein et al. HEART RHYTHM
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Apixaban, an oral, direct and highly selective factor Xa inhibitor:in vitro, antithrombotic and antihemostatic studies
- (2008) P. C. WONG et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation